Potent in vivo CAR T cell generation and durable antitumor activity in preclinical models using VivoVec, a surface-engineered lentiviral vector platform Dan Potent in vivo CAR T cell generation and durable antitumor activity in preclinical models using VivoVec, a surface-engineered lentiviral vector platform Read More »
VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance in vivo CAR T cell generation and antitumor activity Dan VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance in vivo CAR T cell generation and antitumor activity Read More »
In vivo generation of universal CAR T cells that mediate durable anti-tumor immunity through combinatorial targeting with bispecific small molecule adaptors Dan In vivo generation of universal CAR T cells that mediate durable anti-tumor immunity through combinatorial targeting with bispecific small molecule adaptors Read More »
VivoVec: A novel lentiviral-based in vivo CAR T cell generation platform with viral particlesurface engineering incorporating T cell activating and co-stimulatory ligands Dan VivoVec: A novel lentiviral-based in vivo CAR T cell generation platform with viral particlesurface engineering incorporating T cell activating and co-stimulatory ligands Read More »
Development of a Scalable, Suspension Cell Culture-Based Manufacturing Process for VivoVec, A Lentiviral Vector Platform for In Vivo CAR T-Cell Generation Dan Development of a Scalable, Suspension Cell Culture-Based Manufacturing Process for VivoVec, A Lentiviral Vector Platform for In Vivo CAR T-Cell Generation Read More »
